Navigation Links
Amicus Therapeutics Announces Second Quarter 2008 Financial Results
Date:8/7/2008

re-tax charges for changes in the fair value of warrant liability

Use of Non-GAAP Financial Measures

Amicus' "non-GAAP net loss" and "non-GAAP diluted net loss per common share" financial measures are defined as reported, or GAAP, net loss and diluted net loss per common share excluding certain items further discussed below. Amicus' management uses these non-GAAP financial measures to establish financial goals and to gain an understanding of the comparative financial performance of Amicus from year to year and quarter to quarter. Accordingly, Amicus believes investors' understanding of Amicus' financial performance is enhanced as a result of disclosing these non-GAAP financial measures. Non-GAAP net loss and diluted net loss per common share should not be viewed in isolation or as a substitute for reported, or GAAP net loss and diluted net loss per common share.

(1) Stock option expense -- Non-GAAP net loss and diluted net loss per

common share exclude the impact of the stock option expense recorded

in accordance with SFAS No. 123R. Amicus believes that excluding the

impact of expensing stock options better reflects the recurring

economic characteristics of its business.

(2) Other items -- Non-GAAP net loss and diluted net loss per common

share exclude other unusual or non-recurring items that are evaluated

on an individual basis. Amicus' evaluation of whether to exclude an

item for purposes of determining its non-GAAP financial measures

considers both the quantitative and qualitative aspects of the item,

including, among other things (i) its size and nature, (ii) whether

or not it relates to its ongoing business operations, and (iii)

whether or not Amicus expects it to occur as part of its normal

business on a regular basis. Items excluded for purposes of

determining non-GAAP net loss and
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
2. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
3. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
6. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
7. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
8. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
9. Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
10. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
11. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 5, 2015 Big Market Research presents a ... Europe , ( France , ... , UK) and Japan . Current scientific ... report provides the 5-year test volume and sales forecasts by country ... Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests ...
(Date:5/5/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... present at the following conferences in May 2015: ... ,Date:            May 10, ... Officer ,Time:            1:45 ...
(Date:5/5/2015)... 5, 2015 E-QURE (Electric Quick ... a premier provider of innovative medical devices in the ... update to shareholders and the investment community, covering 2014 ... of the proprietary Bioelectrical Signal Therapy™ (BST) Device for ... S-1, as well as its plans for commercialization and ...
Breaking Medicine Technology:2015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3Oramed to Present at Upcoming Conferences 2Oramed to Present at Upcoming Conferences 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 2E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 4E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 5
... SOUTH SAN FRANCISCO, Calif., May 8, 2012  diaDexus, Inc. ... focused on the development and commercialization of proprietary cardiovascular ... quarter of 2012. Total revenues for ... 49% increase over $3.3 million for the first quarter ...
... Mass. and SYDNEY, May 8, 2012  HeartWare International, ... a leading innovator of less invasive, miniaturized circulatory ... advanced heart failure, today announced that enrollment is ... clinical study to evaluate the use of the ...
Cached Medicine Technology:diaDexus, Inc. Reports 2012 First Quarter Financial Results 2diaDexus, Inc. Reports 2012 First Quarter Financial Results 3diaDexus, Inc. Reports 2012 First Quarter Financial Results 4diaDexus, Inc. Reports 2012 First Quarter Financial Results 5HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial 2HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial 3HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial 4
(Date:5/5/2015)... May 05, 2015 With Mother's ... Organics, one of the country's leading organic vegetable ... of moms across the country. What to eat? ... recipe box or spend hours browsing Pinterest – ... http://www.josiesorganics.com/recipes . , The new recipes ...
(Date:5/5/2015)... 2015 Don’t have time to go ... fitness membership? Don’t know which workout equipment to use? ... order to help members achieve their heath and fitness ... an educational, caused-based wellness company, today announces the launch ... classes led by certified trainers, nutritional information and recipes ...
(Date:5/5/2015)... New York, NY (PRWEB) May 05, 2015 ... April 29th and honored Walt “Clyde” Frazier and Cravath, ... support of New York’s highest-need communities. The event was ... & Saul Kupferberg. , “The Next Chapter” highlighted Sheltering ... new name, which was unveiled in February 2015. Formerly ...
(Date:5/5/2015)... May 05, 2015 Buckeye Health Plan ... new CEO and plan president of Buckeye Health Plan. ... the position immediately. , Hill has more than 28 ... the Pacific Northwest, from managed care to large health ... and CEO of HealthPlus of Michigan, a health plan ...
(Date:5/5/2015)... May 05, 2015 NovaSom, Inc., announced ... episode of Innovations with Ed Begley Jr., airing via ... TBA. , This segment will focus on NovaSom, a ... will learn about their AccuSom® home sleep test, which ... provides continuous patient support and next-day test results and ...
Breaking Medicine News(10 mins):Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 4Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 3Health News:Sheltering Arms Honors Walt "Clyde" Frazier and Cravath, Swaine & Moore LLP at Annual Gala 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2
... ... relax patients, treat TMJ disorders and improve dental procedures. , ... Miami, FLA. (PRWEB) -- In addition to cosmetic dentistry services, ... at Miami Beach Dental Institute now offer dental massage to patients. Dr. Nassery teams up ...
... who have been treated for breast cancer can choose to ... put them at higher risk of dying from their cancer, ... of 14 trials, presented today (Friday) at the seventh European ... that, not only was pregnancy safe for breast cancer survivors, ...
... of prescription drugs skyrocketing in the United States, the ... for Social Policy and Management at Brandeis University to ... of these drugs: the PMP Center of Excellence. ... from DOJ,s Bureau of Justice Assistance (BJA), the Center ...
... more women are delaying motherhood, researchers say , THURSDAY, March ... become pregnant after having had breast cancer may actually improve ... experts had thought. , The finding is significant, given ... decline and more women are delaying pregnancy until later in ...
... SoCal Cleanse, a company focused ... Best of Show Award from VegNews at the 2010 Natural Products Expo West show. SoCal ... cleansing line. , ... -- SoCal Cleanse was tapped as winner of the VegNews Best of Show Award ...
... of children and up to 70 percent of adults in ... In recent years, doctors have come to believe that this ... that generate the immature blood cells characteristic of leukemia and ... Hospital Boston have found a possible way to kill off ...
Cached Medicine News:Health News:Top Miami Dentist, Dr. Hamid Nassery, Offers Dental Massage Services For Patients 2Health News:Pregnancy for breast cancer survivors: Meta-analysis reveals it is safe and could improve survival 2Health News:Pregnancy for breast cancer survivors: Meta-analysis reveals it is safe and could improve survival 3Health News:A prescription for excellence 2Health News:Pregnancy May Protect Breast Cancer Survivors 2Health News:Pregnancy May Protect Breast Cancer Survivors 3Health News:SoCal Cleanse Wins 2010 VegNews Best of Show Award 2Health News:Targeting cell pathway may prevent relapse of leukemia 2Health News:Targeting cell pathway may prevent relapse of leukemia 3
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
... with Vacuum Controller V-800 and water-cooled secondary condenser ... Compact Housing Model V-500 is ... handle most vacuum applications. Applications ... rotary evaporators Laboratory vacuum source for ...
... Vacuum Controller V-800 Efficiently controls vacuum levels ... and off as needed to maintain preset vacuum level ... membrane vacuum pump designed to handle most vacuum applications. ... up to two rotary evaporators Laboratory vacuum ...
... The Universal Vacuum System UVS400A is ... system. The UVS400A combines a refrigerated vapor ... in a single integrated unit. The easy-to-use, ... recovered solvent into single jar for easy ...
Medicine Products: